Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Virology Journal|October 30, 2019
Multiplex PCR-based titration (MPBT) assay for determination of infectious titers of the three Sabin strains of live poliovirus vaccineHasmik Manukyan, Elvira Rodionova, Tatiana Zagorodnyaya, et al.
Biologicals : Journal of the International Association of Biological Standardization|August 6, 2013
Collaborative study report: evaluation of the ATCC experimental mycoplasma reference strains panel prepared for comparison of NAT-based and conventional mycoplasma detection methodsAlena Dabrazhynetskaya, Dmitriy V Volokhov, Tsai-Lien Lin, et al.
Scientific Reports|January 24, 2018
Delayed onset of autoreactive antibody production and M2-skewed macrophages contribute to improved survival of TACI deficient MRL-Fas/Lpr mouseLunhua Liu, Windy Rose Allman, Adam Steven Coleman, et al.
Clinical and Vaccine Immunology : CVI|April 9, 2010
Comparison of three anthrax toxin neutralization assaysMiriam M Ngundi, Bruce D Meade, Tsai-Lien Lin, et al.
Nature Communications|July 28, 2019
Repeat vaccination reduces antibody affinity maturation across different influenza vaccine platforms in humansSurender Khurana, Megan Hahn, Elizabeth M Coyle, et al.
Viruses|June 27, 2024
Application of MPBT Assay for Multiplex Determination of Infectious Titers and for Selection of the Optimal Formulation for the Trivalent Novel Oral Poliovirus VaccineHasmik Manukyan, Manjari Lal, Changcheng Zhu, et al.
Plos One|March 10, 2021
Establishment of a well-characterized SARS-CoV-2 lentiviral pseudovirus neutralization assay using 293T cells with stable expression of ACE2 and TMPRSS2Sabari Nath Neerukonda, Russell Vassell, Rachel Herrup, et al.
Clinical and Vaccine Immunology : CVI|October 30, 2009
Development and analytical validation of an immunoassay for quantifying serum anti-pertussis toxin antibodies resulting from Bordetella pertussis infectionSandra L Menzies, Vijay Kadwad, Lucia C Pawloski, et al.
Journal of Pharmaceutical Sciences|February 18, 2016
Subvisible Particle Content, Formulation, and Dose of an Erythropoietin Peptide Mimetic Product Are Associated With Severe Adverse Postmarketing EventsJoseph Kotarek, Christine Stuart, Silvia H De Paoli, et al.
Pageof 1